Portfolio

Building Technology
That Matters

From liquid biopsies to AI-powered neurology to energy-efficient AGI—my work focuses on non-destructive approaches to understanding complex systems. Technology that observes, learns, and serves.

Active • 2022 — Present

AuraSense Tech Corporation

Pioneering generative AI and automation for neurology assessments.

Neurology has long depended on subjective observation—a doctor asking a patient to follow their finger. AuraSense automates this through AI that detects micro-tremors, gaze anomalies, and speech patterns invisible to the human eye.

We're making advanced neurological care accessible and objective—available to anyone with a smartphone camera, not just those with access to specialists.

Generative AI for automated neurological assessment
HapticsHealth and HapticsEM technology platforms
TechCrunch Startup Battlefield participant
HAX/SOSV and mHUB MedTech accelerator graduate
Visit AuraSense

AuraSense

AI-Powered Neurology

cellPhoresis

Non-Destructive Cell Sorting

Active • 2016 — Present

Charlot Biosciences, Inc

Non-destructive cell sorting through electrokinetic mobility.

Traditional flow cytometry kills or damages cells to analyze them. I built CBio on a different philosophy: "We have tools to look inside the body without killing the patient, so why should we have to kill cells to understand disease?"

cellPhoresis technology uses each cell's unique dielectric signature to separate populations without chemical tags or lethal forces. The output: live, viable cells ready for further study.

Label-free cell separation using dielectrophoresis
Electrokinetic mobility ratios (EKMr) for cell identification
COVID-19 resilience technology for viral load monitoring
Visit Charlot Biosciences
Active • 2026 — Present

Open Interface Engineering, Inc

Energy-efficient AGI research and AI-native programming languages.

AI inference is consuming unsustainable amounts of energy. openIE is pioneering hardware-aware AI systems that integrate real-time telemetry—temperature, power, memory pressure—into routing decisions, achieving 70%+ energy savings without sacrificing capability.

Our research includes the Joule programming language (AI-native with energy-aware scheduling), Metabolic Cascade Inference architecture, and open-source whitepapers published for community benefit—no patents, just progress.

72.3% energy savings with zero quality degradation
Joule: AI-native programming language with energy awareness
Open Access research published under CC BY 4.0
Visit openIE

openIE

Energy-Efficient AGI

C3I Tech

Resilient Systems

Active • 2022 — Present

C3I Tech, LLC

Command, control, communications, and intelligence solutions.

Building resilient systems for critical infrastructure and defense applications. Technology that adapts and responds when communities need it most—from emergency response coordination to secure communications infrastructure.

C3I Tech focuses on systems that maintain operational capability under adverse conditions, with emphasis on redundancy, security, and rapid deployment.

Critical infrastructure resilience
Secure communications systems
Emergency response technology
Visit C3I Tech
Active • 2026 — Present

DJC Publishing

Independent publishing across fiction, science, technology, and faith.

20 titles spanning science fiction trilogies, children's adventure series, AI philosophy, literary thrillers, patent law, and explorations of faith. From manuscript development through EPUB production to multi-platform distribution on Amazon, Apple Books, IngramSpark, and Google Play.

Two catalogs organize the collection: Lore for fiction and Fabric for non-fiction. Every book is built with the same engineering rigor brought to the lab and the startup.

20 titles across 15 franchises
LanguageOS trilogy: AI-driven science fiction epic
Multi-format: EPUB, paperback, hardcover, audiobook
Global distribution across 6+ platforms

DJC Publishing

20 Titles • Fiction & Non-Fiction

Past Venture • 2009 — 2016

Biological Dynamics

Liquid biopsy for early cancer detection.

Co-founded this company with a team from UC San Diego to revolutionize cancer diagnostics. We developed technology to isolate cell-free circulating DNA directly from blood—enabling cancer detection without invasive tissue biopsies.

Won first place at the UC San Diego Entrepreneur Challenge in 2009, securing $27,000 in cash and $15,000 in legal services for patent protection. This experience taught me the importance of defending intellectual property from day one.

Liquid biopsy for non-invasive cancer diagnostics
Cell-free DNA isolation from blood samples
UC San Diego Entrepreneur Challenge winner

Liquid Biopsy

Early Cancer Detection

Patents & Research

Patents

5+ patents filed across microfluidics, cell sorting, and biomedical diagnostics. From dielectrophoretic separation methods to integrated detection systems.

View on Justia Patents

Publications

Research published in IEEE and peer-reviewed journals covering bioengineering, microfluidics, and diagnostic technology.

View on Google Scholar

Let's Build Together

Interested in collaboration, investment opportunities, or speaking engagements?

Get in Touch